| 000 | 01827 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517020044.0 | ||
| 264 | 0 | _c20160901 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2015.02.039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBédouet, Laurent | |
| 245 | 0 | 0 |
_aAnti-angiogenic drug delivery from hydrophilic resorbable embolization microspheres: an in vitro study with sunitinib and bevacizumab. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cApr 2015 |
||
| 300 |
_a218-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aEmbolization, Therapeutic _xmethods |
| 650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aVerret, Valentin | |
| 700 | 1 | _aLouguet, Stéphanie | |
| 700 | 1 | _aServais, Emeline | |
| 700 | 1 | _aPascale, Florentina | |
| 700 | 1 | _aBeilvert, Anne | |
| 700 | 1 | _aBaylatry, Minh-Tâm | |
| 700 | 1 | _aLabarre, Denis | |
| 700 | 1 | _aMoine, Laurence | |
| 700 | 1 | _aLaurent, Alexandre | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 484 _gno. 1-2 _gp. 218-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2015.02.039 _zAvailable from publisher's website |
| 999 |
_c24642374 _d24642374 |
||